Fresenius Medical Care FMS
$20.44 +$0.31 (+1.54%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $20.44 0.00%
Open$20.49
Prev close$20.13
Day range$20.38 – $20.72
Volume1.34M
Market cap$10.61B
P/E (TTM)12.5
Dividend yield4.14%
Earnings
Average move on report day±4.1%last 16 reports
Closed higher4 of 1625% of the time
Best reaction+7.0%
Worst reaction-10.9%
Stock move on the day after each report
| Quarter | Report date | Timing | Implied move | Actual move | Versus implied |
|---|---|---|---|---|---|
| 2026/Q3 | 3 Nov 2026 | None | ±15.4% | -3.89% | Within range |
| 2026/Q2 | 4 Aug 2026 | Pre Market | ±6.6% | -4.95% | Within range |
| 2026/Q1 | 5 May 2026 | None | ±22.0% | -10.86% | Within range |
| 2025/Q4 | 24 Feb 2026 | Pre Market | ±12.6% | -7.85% | Within range |
| 2025/Q3 | 4 Nov 2025 | Pre Market | – | -7.82% | – |
| 2025/Q2 | 5 Aug 2025 | Pre Market | – | -2.09% | – |
| 2025/Q1 | 6 May 2025 | Pre Market | ±6.4% | +6.99% | Bigger than priced |
| 2024/Q4 | 25 Feb 2025 | Pre Market | – | +0.60% | – |
| 2024/Q3 | 8 Nov 2024 | None | ±7.9% | -0.14% | Within range |
| 2024/Q2 | 30 Jul 2024 | Pre Market | ±7.6% | -3.59% | Within range |
| 2024/Q1 | 7 May 2024 | None | ±9.5% | -6.12% | Within range |
| 2023/Q4 | 20 Feb 2024 | None | – | -2.32% | – |
| 2023/Q3 | 2 Nov 2023 | None | ±11.0% | +3.29% | Within range |
| 2023/Q2 | 2 Aug 2023 | None | ±11.7% | -2.25% | Within range |
| 2023/Q1 | 12 May 2023 | None | ±8.2% | -1.47% | Within range |
| 2022/Q4 | 22 Feb 2023 | None | ±11.4% | +0.63% | Within range |
"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.
Where the revenue comes from
Quarter 2026/Q3
By business line
Fundamentals
Latest reported quarter: Q3, ended Sep 2026 · reported in EUR
Revenue€4.94B+1.1% YoY
Operating profit€473.05M-6.0% YoY
Net profit€224.80M-31.3% YoY
Diluted EPS€0.31-35.1% YoY
Free cash flow€559.59M+1.9% YoY
Operating cash flow€797.56M
Revenue, last 8 quarters
Net profit, last 8 quarters
Profitability & balance sheet
Gross margin26.5%
Operating margin10.0%
Net margin4.2%
Return on equity6.4%
Return on assets2.6%
Return on invested capital4.6%
Current ratio0.99
Liabilities / assets56.3%
Cash & investments€1.48B
Total debt€10.30B
Net cash (debt)-€8.82B
Free cash flow / sales9.2%
No comments yet — be the first to weigh in on FMS.
Sign in to join the discussion.